Updated efficacy and toxicity analysis of irinotecan and oxaliplatin (IROX) : intergroup trial N9741 in first-line treatment of metastatic colorectal cancer.
- Citation:
- Cancer vol 110 (3) 670-7
- Year:
- 2007
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Long-Term-Followup
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- CA-21115, CA-25224, CA-32102, CA-35101, CA-35195, CA-37404, CA-38926
- Corr. Author:
- Authors:
- Amanda C Ashley Daniel J Sargent Steven R Alberts Axel Grothey Megan E Campbell Roscoe F Morton Charles S Fuchs Ramesh K Ramanathan Stephen K Williamson Brian P Findlay Henry C Pitot Richard M Goldberg
- Networks:
- Study
- NCCTG-9741
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- Adult, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Camptothecin, Colorectal Neoplasms, Disease Progression, Female, Fluorouracil, Humans, Leucovorin, Male, Middle Aged, Organoplatinum Compounds, Survival Rate, Treatment Outcome